Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Henry; James Robert
Address:
Indianapolis, IN
No. of patents:
10
Patents:












Patent Number Title Of Patent Date Issued
8114872 Triazolyl aminopyrimidine compounds February 14, 2012
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.
8101628 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer January 24, 2012
The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. wherein: R.sup.1 hydrogen, hydroxy, halo, methyl, C.sub.1-C.sub.2 alkoxy, amino, or methylamino; R.sup.2 is hydrogen, halo, o
8063212 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer November 22, 2011
The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. Formula I wherein: R.sup.1 is aminomethyl, (C.sub.1-C.sub.3 alkyl)aminomethyl, di(C.sub.1-C.sub.2 alkyl)aminomethyl, N-ethyl-
8063035 Triazolyl aminopyrimidine compounds November 22, 2011
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.
8058425 Purine derivatives as kinase inhibitors November 15, 2011
The present invention provides kinase inhibitors of Formula I. ##STR00001##
8022065 Purine derivatives as kinase inhibitors September 20, 2011
The present invention provides kinase inhibitors of Formula I. ##STR00001##
7666879 Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors February 23, 2010
The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds. ##STR00001##
7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors July 29, 2008
The present invention provides kinase inhibitors of Formula (I) ##STR00001##
7282501 Modulators of peroxisome proliferator activated receptors (PPAR) October 16, 2007
The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arterioscle
6984661 Urea linker derivatives for use as PPAR modulators January 10, 2006
The present invention is directed to compounds of the structural formula (I), and pharmaceutically acceptable salts, solvates and hydrates thereof: Formula I (a) R1, R2 and R6 are each independently selected from the group consisting of hydrogen, C.sub.1-C.sub.8 alkyl substituted C.s










 
 
  Recently Added Patents
Apparatus and method for categorizing services using canonical service descriptions
Passive charge cord release system for an electric vehicle
Cosmetic composition based on a supramolecular polymer and a hyperbranched functional polymer
Rear bumper for an automobile
Method and apparatus for detection of the remote origin fraction of radon present in a measuring site
Process for filtering interferograms obtained from SAR images acquired on the same area
Illuminating device
  Randomly Featured Patents
Methods for assaying expression of novel galanin receptors
Information providing method and information providing device
Adjustable basketball goal
Mass spectrometer
Apparatus for counting and classifying particles
Lid of notebook computer
High-reliability power amplifier
Long life modular link belts suitable for abrasive environments
Stuffed toy helicopter
System, device, and method for wireless communication, apparatus and method for processing information from contactless IC cards